Back to Lynx1 Capital Management LP
Q3 2026 13F filing
Updated 6 days ago31 disclosed positions worth $646.1M
Portfolio value
$646.1M
Total holdings
31
New positions
0
Closed positions
0
Increased
0
Decreased
0
Turnover
—
Filed
2026-11-16
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | G GH RESEARCH PLC | $311.4M | 13.26M | 48.20% | — |
| 2 | C CULLINAN THERAPEUTICS INC | $137.6M | 8.96M | 21.30% | — |
| 3 | S STOKE THERAPEUTICS INC | $101.3M | 3.90M | 15.68% | — |
| 4 | B C4 THERAPEUTICS INC | $25.1M | 7.53M | 3.88% | — |
| 5 | D PRECISION BIOSCIENCES INC | $17.3M | 2.76M | 2.67% | — |
| 6 | M AGIOS PHARMACEUTICALS INC | $15.7M | 472.6K | 2.43% | — |
| 7 | K KORRO BIO INC | $15.3M | 1.54M | 2.37% | — |
| 8 | N NEUPHORIA THERAPEUTICS INC | $3.1M | 875.3K | 0.48% | — |
| 9 | ? N/A PASSAGE BIO INC | $3M | 673.8K | 0.47% | — |
| 10 | P PROQR THRAPEUTICS N V | $2.6M | 1.56M | 0.40% | — |
| 11 | T TSCAN THERAPEUTICS INC | $2.5M | 8.02M | 0.39% | — |
| 12 | K KAZIA THERAPEUTICS LTD | $2.2M | 225.8K | 0.34% | — |
| 13 | P PLIANT THERAPEUTICS INC | $1.9M | 1.80M | 0.30% | — |
| 14 | T ENTRADA THERAPEUTICS INC | $1.8M | 278.6K | 0.27% | — |
| 15 | S SURROZEN INC | $644K | 20.0K | 0.10% | — |
| 16 | I IMMATICS N.V | $626K | 71.3K | 0.10% | — |
| 17 | H WEREWOLF THERAPEUTICS INC | $607K | 657.8K | 0.09% | — |
| 18 | Y YARROW BIOSCIENCE INC | $495K | 22.0K | 0.08% | — |
| 19 | X XENCOR INC | $454K | 18.2K | 0.07% | — |
| 20 | I IMMUNOCORE HLDGS PLC | $433K | 14.3K | 0.07% | — |
| 21 | D DYNE THERAPEUTICS INC | $403K | 25.0K | 0.06% | — |
| 22 | T TRAWS PHARMA INC | $332K | 559.5K | 0.05% | — |
| 23 | D DENALI THERAPEUTICS INC | $241K | 11.7K | 0.04% | — |
| 24 | A ABSCI CORPORATION | $229K | 21.2K | 0.04% | — |
| 25 | F FOGHORN THERAPEUTICS INC | $220K | 61.6K | 0.03% | — |
| 26 | A AVALO THERAPEUTICS INC | $155K | 10.1K | 0.02% | — |
| 27 | P PRIME MEDICINE INC | $137K | 45.0K | 0.02% | — |
| 28 | ? N/A BOLT BIOTHERAPEUTICS INC | $113K | 30.8K | 0.02% | — |
| 29 | E EUPRAXIA PHARMACEUTICALS INC | $91K | 10.0K | 0.01% | — |
| 30 | N NUVATION BIO INC | $90K | 16.0K | 0.01% | — |
| 31 | I INHIBIKASE THERAPEUTICS INC | $1K | 20.0K | 0.00% | — |